BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines GAAP Basic Earnings (Loss) per ADS by Year
GAAP Basic Earnings (Loss) per ADS ($/ADS) ($)
BeOne Medicines GAAP Basic Earnings (Loss) per ADS: $2.63 in FY2025, down 143.0% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Operations (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Basic Earnings (Loss) per ADS ($/ADS) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.63 | -143.0% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -6.12 | -27.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | -8.45 | -56.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | -19.43 | +23.7% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | -15.71 | -19.3% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | -19.47 | +23.2% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | -15.80 | +30.0% | Form 10-K (filed 2022-02-28) ↗ |
| FY2018 | Dec 31, 2018 | -12.15 | +444.8% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | -2.23 | -41.9% | Form 10-K (filed 2020-03-02) ↗ |
| FY2016 | Dec 31, 2016 | -3.84 | -42.8% | Form 10-K (filed 2019-02-28) ↗ |
| FY2015 | Dec 31, 2015 | -6.71 | – | Form 10-K (filed 2018-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines GAAP Basic Earnings (Loss) per ADS ($), annual FY2015–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/eps-ads-basic
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.